Skip to main content
Top
Published in: Osteoporosis International 5/2014

Open Access 01-05-2014 | Position Paper

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

Authors: E. S. Siris, R. Adler, J. Bilezikian, M. Bolognese, B. Dawson-Hughes, M. J. Favus, S. T. Harris, S. M. Jan de Beur, S. Khosla, N. E. Lane, R. Lindsay, A. D. Nana, E. S. Orwoll, K. Saag, S. Silverman, N. B. Watts

Published in: Osteoporosis International | Issue 5/2014

Login to get access

Abstract

Summary

Osteoporosis causes an elevated fracture risk. We propose the continued use of T-scores as one means for diagnosis but recommend that, alternatively, hip fracture; osteopenia-associated vertebral, proximal humerus, pelvis, or some wrist fractures; or FRAX scores with ≥3 % (hip) or 20 % (major) 10-year fracture risk also confer an osteoporosis diagnosis.

Introduction

Osteoporosis is a common disorder of reduced bone strength that predisposes to an increased risk for fractures in older individuals. In the USA, the standard criterion for the diagnosis of osteoporosis in postmenopausal women and older men is a T-score of ≤ −2.5 at the lumbar spine, femur neck, or total hip by bone mineral density testing.

Methods

Under the direction of the National Bone Health Alliance, 17 clinicians and clinical scientists were appointed to a working group charged to determine the appropriate expansion of the criteria by which osteoporosis can be diagnosed.

Results

The group recommends that postmenopausal women and men aged 50 years should be diagnosed with osteoporosis if they have a demonstrable elevated risk for future fractures. This includes having a T-score of less than or equal to −2.5 at the spine or hip as one method for diagnosis but also permits a diagnosis for individuals in this population who have experienced a hip fracture with or without bone mineral density (BMD) testing and for those who have osteopenia by BMD who sustain a vertebral, proximal humeral, pelvic, or, in some cases, distal forearm fracture. Finally, the term osteoporosis should be used to diagnose individuals with an elevated fracture risk based on the World Health Organization Fracture Risk Algorithm, FRAX.

Conclusions

As new ICD-10 codes become available, it is our hope that this new understanding of what osteoporosis represents will allow for an appropriate diagnosis when older individuals are recognized as being at an elevated risk for fracture.
Literature
1.
go back to reference NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) NIH consensus development panel on osteoporosis prevention, diagnosis and treatment. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) NIH consensus development panel on osteoporosis prevention, diagnosis and treatment. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRef
2.
go back to reference Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S (2012) What’s in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int 23(8):2093–2097PubMedCrossRef Siris ES, Boonen S, Mitchell PJ, Bilezikian J, Silverman S (2012) What’s in a name? What constitutes the clinical diagnosis of osteoporosis? Osteoporos Int 23(8):2093–2097PubMedCrossRef
5.
go back to reference Watts NB, Bilezikian JP, Camacho PM et al (2010) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1–37PubMed Watts NB, Bilezikian JP, Camacho PM et al (2010) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 16(Suppl 3):1–37PubMed
6.
go back to reference Sweet MG, Sweet JM, Jeremiah MP, Galazka SS (2009) Diagnosis and treatment of osteoporosis. Am Fam Physician 79(3):193–200PubMed Sweet MG, Sweet JM, Jeremiah MP, Galazka SS (2009) Diagnosis and treatment of osteoporosis. Am Fam Physician 79(3):193–200PubMed
7.
go back to reference Lewiecki EM, Laster AJ, Miller PD, Bilezikian JP (2012) More bone density testing is needed, not less. J Bone Miner Res 27(4):739–742PubMedCrossRef Lewiecki EM, Laster AJ, Miller PD, Bilezikian JP (2012) More bone density testing is needed, not less. J Bone Miner Res 27(4):739–742PubMedCrossRef
8.
go back to reference Wainwright SA, Marshall LM, Ensrud KE et al (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793PubMedCrossRef Wainwright SA, Marshall LM, Ensrud KE et al (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793PubMedCrossRef
9.
go back to reference Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323PubMedCrossRef Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285(3):320–323PubMedCrossRef
10.
go back to reference Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 27(3):645–653PubMedCrossRef Gehlbach S, Saag KG, Adachi JD et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 27(3):645–653PubMedCrossRef
11.
go back to reference Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed
12.
go back to reference Schuit SCE, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1):195–202PubMedCrossRef Schuit SCE, van der Klift M, Weel AE et al (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34(1):195–202PubMedCrossRef
13.
go back to reference Siris ES, Chen Y, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108–1112PubMedCrossRef Siris ES, Chen Y, Abbott TA et al (2004) Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 164(10):1108–1112PubMedCrossRef
14.
go back to reference Barrett-Connor E, Sajjan SG, Siris ES, Miller PD (2008) Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 19(5):607–613PubMedCrossRef Barrett-Connor E, Sajjan SG, Siris ES, Miller PD (2008) Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 19(5):607–613PubMedCrossRef
15.
go back to reference Kanis J (2008) Assessment of osteoporosis at the primary healthcare level. World Health Organization Collaborating Centre, University of Sheffield, Sheffield, UK Kanis J (2008) Assessment of osteoporosis at the primary healthcare level. World Health Organization Collaborating Centre, University of Sheffield, Sheffield, UK
16.
go back to reference Tosteson AN, Melton LJ 3rd, Dawson-Hughes B et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437–447PubMedCentralPubMedCrossRef Tosteson AN, Melton LJ 3rd, Dawson-Hughes B et al (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19(4):437–447PubMedCentralPubMedCrossRef
17.
go back to reference Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for the treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822PubMedCrossRef Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for the treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822PubMedCrossRef
18.
go back to reference Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809PubMedCrossRef Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809PubMedCrossRef
19.
go back to reference Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434–1441PubMedCrossRef Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434–1441PubMedCrossRef
20.
go back to reference McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo- controlled randomised study. Osteoporos Int 20(5):811–817PubMedCrossRef McCloskey EV, Johansson H, Oden A et al (2009) Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo- controlled randomised study. Osteoporos Int 20(5):811–817PubMedCrossRef
21.
go back to reference Donaldson MG, Palermo L, Ensrud K, Hochberg MC, Schousboe JT, Cummings SR (2012) Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res 27(8):1804–1810PubMedCrossRef Donaldson MG, Palermo L, Ensrud K, Hochberg MC, Schousboe JT, Cummings SR (2012) Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res 27(8):1804–1810PubMedCrossRef
22.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRef Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRef
Metadata
Title
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
Authors
E. S. Siris
R. Adler
J. Bilezikian
M. Bolognese
B. Dawson-Hughes
M. J. Favus
S. T. Harris
S. M. Jan de Beur
S. Khosla
N. E. Lane
R. Lindsay
A. D. Nana
E. S. Orwoll
K. Saag
S. Silverman
N. B. Watts
Publication date
01-05-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 5/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2655-z

Other articles of this Issue 5/2014

Osteoporosis International 5/2014 Go to the issue